Lorazepam and Gemtesa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Gemtesa (vibegron). Common drug interactions include fall among females and clumsiness among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Gemtesa. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Gemtesa?

Gemtesa has active ingredients of vibegron. eHealthMe is studying from 2,648 Gemtesa users. Check the latest studies of Gemtesa.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

17 people who take Lorazepam and Gemtesa together, and have interactions are studied.

Lorazepam and Gemtesa drug interactions.

What are the common drug interactions of Lorazepam and Gemtesa, by gender? *:

female:

Fall
Malaise (a feeling of general discomfort or uneasiness)
Pain
Urinary tract infection
Catheter site haematoma (blood clot at catheter site)
Dyspnoea (difficult or laboured respiration)
Faeces discoloured
Herpes zoster
Infusion related reaction
Infusion site pain

male:

Clumsiness (a lack of coordination or elegance)
Fall
Injection site discharge
Injection site pain
Pain
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Lorazepam and Gemtesa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Asthma
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Fungal infection
Headache (pain in head)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Injection site erythema (redness at injection site)
Injection site pruritus (severe itching at injection site)
Injection site rash

50-59:

Fall
Pain
Palpitations (feelings or sensations that your heart is pounding or racing)
Arthralgia (joint pain)
Asthenia (weakness)
Back pain
Breast pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chest pain
Clumsiness (a lack of coordination or elegance)

60+:

Enuresis (repeated inability to control urination)
Asthenia (weakness)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Malaise (a feeling of general discomfort or uneasiness)
Neuropathy peripheral (surface nerve damage)
Psychotic disorder
Renal failure (kidney dysfunction)
Sinusitis (inflammation of sinus)
Urinary retention (the inability to completely or partially empty the bladder)
Urinary tract infection

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 23.53%
Immunodeficiency Common Variable: 4 people, 23.53%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 17.65%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 17.65%
High Blood Cholesterol: 2 people, 11.76%
Asthma: 2 people, 11.76%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 11.76%
Delusion (a false belief or opinion): 2 people, 11.76%
Dyspnea (difficult or laboured breathing): 2 people, 11.76%
Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Gemtesa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously